BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10022628)

  • 1. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
    Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
    J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
    Lachman L; Howden CW
    Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
    Kiilerich S; Rannem T; Elsborg L
    Digestion; 1995; 56(1):25-30. PubMed ID: 7895928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Miner PB; Allgood LD; Grender JM
    Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
    Leite LP; Johnston BT; Just RJ; Castell DO
    Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects.
    Bruley des Varannes S; Gharib H; Bicheler V; Bost R; Bonaz B; Stanescu L; Delchier JC; Bonnot-Marlier S
    Aliment Pharmacol Ther; 2004 Oct; 20(8):899-907. PubMed ID: 15479362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of single intravenously administered doses of omeprazole and ranitidine on intragastric pH and plasma gastrin concentration in nonfed ponies.
    Baker SJ; Gerring EL
    Am J Vet Res; 1993 Dec; 54(12):2068-74. PubMed ID: 8116940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
    Merki HS; Wilder-Smith CH
    Gastroenterology; 1994 Jan; 106(1):60-4. PubMed ID: 8276209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.
    Hsieh YH; Lin HJ; Tseng GY; Perng CL; Wang K; Lo WC; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(55):316-9. PubMed ID: 15011893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
    Labenz J; Peitz U; Leusing C; Tillenburg B; Blum AL; Börsch G
    Gut; 1997 Jan; 40(1):36-41. PubMed ID: 9155573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of octreotide on intragastric pH in patients with duodenal ulcer bleeding].
    Nie Y; Li Y; Sha W; Dai S; She Q; Wu H
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):520-2. PubMed ID: 11809113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine.
    Ley LM; Becker A; Lühmann R; Sander P; Lücker PW
    Methods Find Exp Clin Pharmacol; 2005; 27(1):25-9. PubMed ID: 15834456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S; Santucci L; Morelli A
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
    J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of intravenous ranitidine and omeprazole effect on the 24-hour gastric ph-metry in duodenal ulcer hemorrhage].
    Artal A; Lanas A; Barrao ME; Moliner FJ; Blas JM; López J
    Rev Esp Enferm Dig; 1996 Mar; 88(3):191-6. PubMed ID: 8645512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study.
    Simon-Rudler M; Massard J; Bernard-Chabert B; DI Martino V; Ratziu V; Poynard T; Thabut D
    Aliment Pharmacol Ther; 2007 Apr; 25(8):949-54. PubMed ID: 17402999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.